Detalles de la búsqueda
1.
Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis.
Acta Derm Venereol
; 101(11): adv00585, 2021 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34618162
2.
Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
Acta Derm Venereol
; 99(10): 851-857, 2019 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31099402
3.
Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use.
Acta Derm Venereol
; 101(7): adv00504, 2021 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34043020
4.
Dupilumab reduces absenteeism in patients with moderate to severe atopic dermatitis: Pooled results from the LIBERTY AD SOLO clinical trials.
J Am Acad Dermatol
; 83(5): 1499-1501, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32504724
5.
Impact of the Family and Household Environment on Pediatric Atopic Dermatitis in Japan.
J Clin Med
; 12(8)2023 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37109324
6.
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials.
Am J Clin Dermatol
; 24(3): 469-483, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36808602
7.
Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.
Dermatol Ther (Heidelb)
; 13(9): 2107-2120, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37552431
8.
Dupilumab Treatment Reduces Hospitalizations in Adults With Moderate-to-Severe Atopic Dermatitis.
J Allergy Clin Immunol Pract
; 10(5): 1279-1285.e1, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35032695
9.
Health utility estimation in children and adolescents: a review of health technology assessments.
Curr Med Res Opin
; 36(7): 1209-1224, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32345060
10.
Health Care Resource Utilization and Costs Among Adults with Atopic Dermatitis in the United States: A Claims-Based Analysis.
J Allergy Clin Immunol Pract
; 6(4): 1342-1348, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29174063
11.
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials.
Am J Clin Dermatol
; 24(4): 673, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37193879
12.
Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults.
Dermatol Ther (Heidelb)
; 7(4): 493-505, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28933010
13.
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
J Neurol
; 260(10): 2472-80, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23852658
14.
Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation--results for Canada, Italy, Sweden and Switzerland.
Eur J Health Econ
; 14(3): 481-93, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22552487
Resultados
1 -
14
de 14
1
Próxima >
>>